Latest News
Kopran Limited
- Medicine Authority European Union conducts GMP inspection at Kopran's Khopoli Facility
- Kopran concludes EU GMP inspection at Khopoli with no critical findings
- Kopran Reports Successful Inspection Of Khopoli Facility With No Major Concerns
- Kopran NSE:KOPRAN EU GMP Inspection Khopoli Plant Outcome
- Kopran Ltd Successfully Concludes EU Medicine Authority Inspection at Khopoli Facility
- Kopran (KOPRAN.NS) Earnings Outlook: Key Metrics for Q2 2026 - Profit Warning Alert
- Kopran Q2 2026 Earnings: Revenue Climbs 8.28% YoY as EPS Comes in at ₹5.33 - Post-Announcement Reaction
- Kopran Share Price Falls 8.55%: Price Action
- KOPRAN.NS Q2 2026 Earnings: Revenue Climbs 8.28% YoY as EPS Reaches ₹5.33 - Earnings Outlook Update
- KOPRAN.NS Q2 2026 Earnings: EPS of ₹5.33 and 8.28% Revenue Growth Lift Shares 4.5% - Earnings Forecast Report
- Kopran NSE:KOPRAN Trading Window Closed Q2 FY27
Headlines from the last 30 days, linking to the original publishers. See all market news →